We are live on ! Find out more
KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

77 hedge funds and large institutions have $328M invested in Chinook Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

249% more capital invested

Capital invested by funds: $93.9M → $328M (+$234M)

88% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 16

47% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 17

10% more funds holding

Funds holding: 70 → 77 (+7)

55% less call options, than puts

Call options by funds: $493K | Put options by funds: $1.09M

Holders
77
Holders Change
+7
Holders Change %
+10%
% of All Funds
1.36%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
25
Increased
30
Reduced
16
Closed
17
Calls
$493K
Puts
$1.09M
Net Calls
-$600K
Net Calls Change
-$604K

Top Buyers

Rank Fund Capital Flow
1
ALSV
ATP Life Science Ventures
New York
+$60.8M
2
SB
Samsara BioCapital
California
+$47.8M
3
EC
EcoR1 Capital
California
+$18.9M
4
O
OrbiMed
New York
+$18.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$11.3M

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.5M
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$1.38M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$1.16M
4
Renaissance Technologies
Renaissance Technologies
New York
-$614K
5
BCM
Burrage Capital Management
Massachusetts
-$330K
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
26
Artal Group
Luxembourg
$2.86M – – –
Janus Henderson Group
27
Janus Henderson Group
United Kingdom
$2.75M +$2.62M +173,551 New
Bank of America
28
Bank of America
North Carolina
$2.51M +$2.38M +157,900 +80,974%
AAA
29
Affinity Asset Advisors
New York
$2.38M +$2.26M +150,000 New
Millennium Management
30
Millennium Management
New York
$1.59M +$1.51M +100,333 New
Two Sigma Advisers
31
Two Sigma Advisers
New York
$1.48M +$309K +20,460 +28%
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$1.33M -$1.16M -76,605 -48%
N
33
Nuveen
North Carolina
$1.19M +$79.7K +5,281 +8%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.16M +$192K +12,710 +21%
Ensign Peak Advisors
35
Ensign Peak Advisors
Utah
$1.1M – – –
Two Sigma Investments
36
Two Sigma Investments
New York
$1.06M +$438K +29,002 +76%
Acadian Asset Management
37
Acadian Asset Management
Massachusetts
$969K -$1.5M -99,464 -62%
Wells Fargo
38
Wells Fargo
California
$914K +$17.5K +1,159 +2%
PAM
39
Panagora Asset Management
Massachusetts
$912K -$37.3K -2,475 -4%
Charles Schwab
40
Charles Schwab
California
$654K +$114K +7,583 +23%
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$567K +$453K +30,054 +529%
AA
42
ALPS Advisors
Colorado
$459K +$124K +8,240 +40%
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$452K +$386K +25,593 +890%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$439K -$46.7K -3,098 -10%
AllianceBernstein
45
AllianceBernstein
Tennessee
$384K -$39.2K -2,600 -10%
Morgan Stanley
46
Morgan Stanley
New York
$351K +$294K +19,496 +749%
Goldman Sachs
47
Goldman Sachs
New York
$330K +$119K +7,860 +61%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$316K -$15 -1 -0%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$295K +$281K +18,600 New
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$267K +$15.4K +1,019 +6%
1
2
3 4

KDNY Hedge Fund Activity: Q4 2020 in Review

77 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Chinook Therapeutics, Inc. Common Stock (KDNY) for Q4 2020, worth a combined $328M — up 249% from $93.9M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new KDNY positions and 17 closed out — a net gain of 8 holders — while 30 added to existing stakes and 16 trimmed.

The largest buyer was ATP Life Science Ventures, opening a new position worth an estimated $60.8M. The largest seller was Acadian Asset Management, cutting an estimated $1.5M.

  • 77 institutional investors held Chinook Therapeutics, Inc. Common Stock (KDNY) as of Q4 2020, up from 70 in Q3 2020.
  • Funds reported $328M of Chinook Therapeutics, Inc. Common Stock stock for Q4 2020, up 249% quarter-over-quarter.
  • 25 funds opened new Chinook Therapeutics, Inc. Common Stock positions in Q4 2020 and 17 closed out, a net change of +8 holders.
  • The largest Chinook Therapeutics, Inc. Common Stock buyer in Q4 2020 was ATP Life Science Ventures, an estimated $60.8M added.
  • The largest Chinook Therapeutics, Inc. Common Stock seller in Q4 2020 was Acadian Asset Management, an estimated $1.5M sold.

Based on aggregated 13F filings for Q4 2020.